What's Driving Abbott's Gross Margin Growth Amid Macro Issues

In the second quarter, Abbott Laboratories ABT posted gross profit of $6.29 billion, up 8.9% year over year despite a 5.4% increase in the cost of products sold (excluding amortization expense). This led to a gross margin expansion of 79 basis points (bps) to 56.4%, backed by a favorable product...